Detalhe da pesquisa
1.
AGILE SCORES IN MASLD AND ALD: EXTERNAL VALIDATION AND THEIR UTILITY IN CLINICAL ALGORITHMS.
J Hepatol
; 2024 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38789011
2.
Development and validation of a scoring system to predict response to obeticholic acid in primary biliary cholangitis.
Clin Gastroenterol Hepatol
; 2024 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38782175
3.
Mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis: A validated prediction model.
Hepatology
; 77(2): 476-488, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35921493
4.
Non-Invasive Diagnostic Tests for Portal Hypertension in Patients with HBV- and HCV-Related Cirrhosis: A Comprehensive Review.
Medicina (Kaunas)
; 60(5)2024 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38792873
5.
Glecaprevir/Pibrentasvir is safe and effective in Italian patients with chronic hepatitis C aged 75 years or older: A multicentre study.
Liver Int
; 43(7): 1440-1445, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37122194
6.
RESIST-HCV Criteria to Monitor Progression of Low-Risk Esophageal Varices in Patients With Compensated Cirrhosis After HCV Eradication: The SIMPLE Study: SIMPLE: Scoring Index to Monitor Progression of Low-risk Esophageal varices.
Am J Gastroenterol
; 117(11): 1816-1824, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35973181
7.
Accuracy of Transient Elastography in Assessing Fibrosis at Diagnosis in Naïve Patients With Primary Biliary Cholangitis: A Dual Cut-Off Approach.
Hepatology
; 74(3): 1496-1508, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33724515
8.
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid.
Liver Int
; 42(11): 2453-2465, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35932095
9.
Refining the Baveno VI elastography criteria for the definition of compensated advanced chronic liver disease.
J Hepatol
; 74(5): 1109-1116, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33307138
10.
Liver and cardiovascular mortality after hepatitis C virus eradication by DAA: Data from RESIST-HCV cohort.
J Viral Hepat
; 28(8): 1190-1199, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33896097
11.
Long-term evolution of LI-RADS observations in HCV-related cirrhosis treated with direct-acting antivirals.
Liver Int
; 41(9): 2179-2188, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33908147
12.
Resistance analysis and treatment outcomes in hepatitis C virus genotype 3-infected patients within the Italian network VIRONET-C.
Liver Int
; 41(8): 1802-1814, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33497016
13.
Hepatic benefits of HCV cure.
J Hepatol
; 73(6): 1548-1556, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32777323
14.
Aminopyrine breath test predicts liver-related events and death in HCV-related cirrhosis on SVR after DAA therapy.
Liver Int
; 40(3): 530-538, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31507057
15.
Hepatitis C virus eradication by direct antiviral agents abates oxidative stress in patients with advanced liver fibrosis.
Liver Int
; 40(11): 2820-2827, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32666695
16.
Reduced incidence of type 2 diabetes in patients with chronic hepatitis C virus infection cleared by direct-acting antiviral therapy: A prospective study.
Diabetes Obes Metab
; 22(12): 2408-2416, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32761721
17.
Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients.
J Hepatol
; 71(2): 265-273, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30959157
18.
Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents.
Gastroenterology
; 155(2): 411-421.e4, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29655836
19.
Is Transient Elastography Needed for Noninvasive Assessment of High-Risk Varices? The REAL Experience.
Am J Gastroenterol
; 114(8): 1275-1282, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31135449
20.
Point-of-care HCV RNA testing in the setting of DAA therapy: HCV-FiS (HEpatitis C Virus Fingerstick Study).
Liver Int
; 39(12): 2240-2243, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31502755